Varaico: Literature-Extracted Genetic Variants

Gene:DNM1
Variant:p.G359A
Back to variants list

DNM1

NM_004408.4:p.G359A

Associated Papers

RNA-based therapies for neurodevelopmental disorders: innovative tools for molecular correction.

Drongitis D et al.

Frontiers in Molecular Biosciences, 2025

PgxSAVy: A tool for comprehensive evaluation of variant peptide quality in proteogenomics - catching the (un)usual suspects.

Raj A et al.

Computational and Structural Biotechnology Journal, 2024

38292474 (PubMed )
Supplement: mmc3.xlsx › AD_DiseaseAnnotation

Effective knockdown-replace gene therapy in a novel mouse model of DNM1 developmental and epileptic encephalopathy.

Jones DJ et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy, 2024

Genotypes and phenotypes of DNM1 encephalopathy.

Kim J et al.

Journal of Medical Genetics, 2023

A deep intronic variant in DNM1 in a patient with developmental and epileptic encephalopathy creates a splice acceptor site and affects only transcript variants including exon 10a.

Harms FL et al.

Neurogenetics, 2023

The dynamin Vps1 mediates Atg9 transport to the sites of autophagosome formation.

Arlt H et al.

The Journal of Biological Chemistry, 2023

Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.

Afsar T et al.

Frontiers in Pediatrics, 2023

Synaptopathies in Developmental and Epileptic Encephalopathies: A Focus on Pre-synaptic Dysfunction.

Spoto G et al.

Frontiers in Neurology, 2022

Semantic Similarity Analysis Reveals Robust Gene-Disease Relationships in Developmental and Epileptic Encephalopathies.

Galer PD et al.

American Journal of Human Genetics, 2020

32853554 (PubMed )
Supplement: mmc2.xlsx › S6

Clinical Assessments and EEG Analyses of Encephalopathies Associated With Dynamin-1 Mutation.

Li H et al.

Frontiers in Pharmacology, 2019

Mutations in the PH Domain of DNM1 are associated with a nonepileptic phenotype characterized by developmental delay and neurobehavioral abnormalities.

Brereton E et al.

Molecular Genetics & Genomic Medicine, 2018

A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations.

Zhu X et al.

Plos Genetics, 2017

29186148 (PubMed )
Supplement: pgen.1007104.s002.xlsx › S1_Table

DNM1 encephalopathy: A new disease of vesicle fission.

von Spiczak S et al.

Neurology, 2017

Insights into dynamin-associated disorders through analysis of equivalent mutations in the yeast dynamin Vps1.

Moustaq L et al.

Microbial Cell (graz, Austria), 2016

In silico prioritization based on coexpression can aid epileptic encephalopathy gene discovery.

Oliver KL et al.

Neurology. Genetics, 2016

27066588 (PubMed )
Supplement: supp_2.1.e51_table_e-2.xlsx › table_e-2

De novo DNM1 mutations in two cases of epileptic encephalopathy.

Nakashima M et al.

Epilepsia, 2016

Novel Genes of Early-Onset Epileptic Encephalopathies: From Genotype to Phenotypes.

Mastrangelo M

Pediatric Neurology, 2015

Independent Neuronal Origin of Seizures and Behavioral Comorbidities in an Animal Model of a Severe Childhood Genetic Epileptic Encephalopathy.

Asinof SK et al.

Plos Genetics, 2015

Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis.

Dhindsa RS et al.

Neurology. Genetics, 2015

De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.

Unknown Author

American Journal of Human Genetics, 2014

Breaking the Synaptic Vesicle Cycle: Mechanistic Insights into Presynaptic Dysfunctions in Epilepsy.

Jiang K et al.

Epilepsy Currents, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."